InvAscent

InvAscent, established in 2006, is a growth-focused investment firm headquartered in Telangana, India. It specializes in providing private equity growth capital to small and mid-sized companies in the Indian pharmaceutical, healthcare, animal health, and medical technology sectors. The firm typically invests USD 10-40 million over the life of an investment, seeking a significant minority stake. It supports these companies in their expansion, product development, and acquisition strategies through its funds, including India Life Sciences Fund I, II, and III.

Hari Buggana

Founder, Chairman and Managing Director

Nilay Doshi

Principal Officer

Nithya Govind

Managing Director

Sumit Gupta

Managing Director

Anil Jagirdar

Director, Investments

T.P. Devarajan

Managing Director

31 past transactions

SRV Hospital

Private Equity Round in 2025
SRV Hospital provides plastic surgery, psychiatry, pediatrics and neonatology, orthopedics, oncology, physiotherapy, neurology, nephrology, gynecology and obstetrics, general surgery-laparoscopy, gastroenterology, ent, dietetics, dermatology, pulmonary/respiratory medicine, and cardiology services.

Maiva Pharma

Private Equity Round in 2024
Maiva Pharma is a manufacturer based in Krishnagiri, Tamil Nadu, specializing in liquid sterile formulations. The company produces small volume glass vials, ampoules, and large volume glass bottles. It provides comprehensive services that include pharmaceutical formulation development, analytical methods development, product licensing, and nitrosamine risk assessment. Maiva Pharma focuses on ensuring the quality and safety of its sterile products, catering to the needs of the pharmaceutical industry.

Fleming Laboratories

Private Equity Round in 2023
Fleming Laboratories is a manufacturer and supplier of generic active pharmaceutical ingredients (APIs) for the global pharmaceutical industry. The company specializes in API development, offering a comprehensive range of services that includes research and development, manufacturing, quality management, and regulatory affairs. Additionally, Fleming Laboratories emphasizes infrastructure and management practices related to environment, health, and safety. Their commitment to quality and customer service is evident as they respond to inquiries via phone and email.

ABI Health

Private Equity Round in 2023
ABI Health is a company that specializes in healthcare technology, focusing on health exchange and image management cloud software solutions. Established in 2013 and headquartered in Bengaluru, India, with additional offices in the United States and Peru, ABI Health operates a platform that enhances patient engagement and collaboration among healthcare providers. The company's offerings include a comprehensive imaging suite called Spectra, which facilitates diagnostic imaging and measurement tools, connecting doctors, hospitals, and patients effectively. ABI Health also develops a range of clinical and mobile applications, cloud services, business intelligence tools, patient portals, and consumer health applications. Furthermore, the company provides consulting services, ensuring interoperability of medical technologies and streamlining data integration to improve healthcare delivery. By leveraging data science and deep learning, ABI Health aims to enhance patient care and support healthcare professionals in managing information efficiently.

Pregna International

Private Equity Round in 2023
Manufacturer of contraceptive devices intended to empower women to lead a stress-free life. The company offers contraceptive devices like cryopop, eloira, esa, pregna copper and etherena, thereby helping women to avoid with unwanted pregnancy.

Sunways

Private Equity Round in 2022
Sunways is a pharmaceutical company that specializes in the manufacture and marketing of a diverse range of formulations, primarily in the fields of ophthalmology and ear, nose, and throat (ENT) care. The company produces medicines aimed at treating eye-related diseases and conditions, offering products such as antibiotics, antioxidants, vitreoretinal protectors, as well as treatments for glaucoma and cataracts. These products are developed under the technical supervision of industry experts, ensuring high standards of production and quality assurance. Sunways is committed to providing sterile ophthalmic and ENT products to meet the needs of healthcare professionals and patients.

Accumax

Private Equity Round in 2022
Accumax is a manufacturer of liquid handling products and lab consumables, primarily serving the clinical, biotechnology, molecular biology, life science, pharmaceutical, and biopharmaceutical sectors. The company offers a diverse range of products, including pipettes, dispensers, controllers, pipette tips, centrifuge tubes, PCR consumables, and deep well plates. Accumax focuses on delivering precision and ease of use in laboratory settings, ensuring that researchers have reliable tools to support their work.

Malladi Drugs & Pharmaceuticals

Private Equity Round in 2022
Malladi Drugs & Pharmaceuticals, established in 1980 and headquartered in Chennai, India, with a U.S. manufacturing facility in Carlstadt, New Jersey, specializes in the production of active pharmaceutical ingredients (APIs). The company focuses on the cough and cold segment, while also serving other therapeutic areas such as antihistamines, anticonvulsants, antidepressants, and anxiolytics. Malladi offers contract manufacturing, custom synthesis, and contract research services, marketing its products both domestically and internationally.

MediBuddy

Series C in 2022
MediBuddy is a digital healthcare platform designed to provide seamless access to a variety of healthcare services, including online doctor consultations, lab tests, and medicine delivery. Its mission is to make quality healthcare accessible and affordable for everyone, regardless of time or location. The platform enables patients to consult with specialist doctors through calls or chat, share medical reports, and receive online consultations and prescriptions. With the capability to offer medical support within half an hour's notice, MediBuddy leverages technology to effectively connect patients with healthcare providers, thereby bridging the gap in healthcare accessibility.

MediBuddy

Series B in 2021
MediBuddy is a digital healthcare platform designed to provide seamless access to a variety of healthcare services, including online doctor consultations, lab tests, and medicine delivery. Its mission is to make quality healthcare accessible and affordable for everyone, regardless of time or location. The platform enables patients to consult with specialist doctors through calls or chat, share medical reports, and receive online consultations and prescriptions. With the capability to offer medical support within half an hour's notice, MediBuddy leverages technology to effectively connect patients with healthcare providers, thereby bridging the gap in healthcare accessibility.

Inventia Healthcare

Private Equity Round in 2020
Inventia Healthcare Limited is a Mumbai-based company that develops, manufactures, and sells a range of pharmaceutical formulations in India and internationally. Founded in 1985, it specializes in novel drug delivery systems and solid oral dosage forms, including tablets, capsules, DC granules, and pellets. The company’s product portfolio spans various therapeutic areas such as anti-diabetic, gastrointestinal, cardiovascular, central nervous system, pain management, urinogenital, anti-infective, respiratory, and musculoskeletal segments. In addition to its domestic operations, Inventia Healthcare exports its products to numerous countries across Asia, North America, Latin America, the Middle East, Africa, and Europe. The company is also engaged in contract research and manufacturing services, supporting both domestic and international pharmaceutical companies with formulation development projects.

Murli Krishna Pharma

Private Equity Round in 2020
Murli Krishna Pharma Private Limited is a Pune-based company established in 2004 that specializes in developing and manufacturing advanced drug delivery systems. The company focuses on aqueous-based technology to produce a variety of pharmaceutical formulations, including pellets, micro-pellets, and granules. Its product lineup features medications such as azithromycin, budesonide, clarithromycin, dex rabeprazole, and domperidone, among others. Murli Krishna Pharma operates a facility compliant with Good Manufacturing Practices (GMP) as recognized by the World Health Organization and the European Union, allowing it to undertake formulation development projects for oral novel drug delivery systems. By offering contract research and manufacturing services, the company aims to provide innovative and effective solutions to optimize the delivery of pharmaceutical products.

Sharp Sight Eye Hospitals

Private Equity Round in 2020
Sharp Sight Laser Centre Private Limited is a New Delhi-based network of eye care clinics established in 1998, specializing in comprehensive and affordable ophthalmology services across North India. The organization provides a wide range of services, including eye testing, cataract surgery, treatments for glaucoma and retinal conditions, as well as services for cornea, pediatric eye issues, and orbit disorders. By focusing on high-quality care, Sharp Sight aims to effectively address various eye care disorders, ensuring accessible and modern treatment options for its patients.

Ankura Hospital

Private Equity Round in 2019
Ankura Hospitals operates a network of healthcare facilities in Hyderabad, focusing on the medical needs of women and children. Founded in 2011, the hospital chain provides a range of gynecological services, including obstetrics, painless delivery, and infertility treatments. For pediatric care, Ankura offers services such as general pediatrics, neonatal intensive care, pediatric intensive care, and specialized treatments in pediatric neurology and gastroenterology. The hospitals are dedicated to delivering quality healthcare in a safe and supportive environment, ensuring comprehensive care for their patients.

Intron Life Sciences

Private Equity Round in 2019
Intron Life Sciences Private Limited is a biotechnology company based in Hyderabad, India, that specializes in manufacturing probiotic products for the poultry and aquaculture industries. Established in 2018, the company offers a diverse range of products, including various probiotics and feed supplements designed to enhance animal health and productivity. Its product lineup for poultry includes items such as Lactomax Gold and Rapigrow, while its aquaculture offerings comprise products like Pondfresh and Biogran. In addition to standard products, Intron Life Sciences also provides custom-made probiotic solutions tailored to the specific needs of clients in the food, poultry, and aquaculture sectors. The company emphasizes sustainable farming practices and is dedicated to ongoing research and development to innovate and enhance its product offerings.

Symbiotec Pharmalab

Private Equity Round in 2018
Symbiotec Pharmalab Ltd. is a manufacturer and exporter of research-based active pharmaceutical ingredients (APIs) specializing in corticosteroids. Established in 1995 and located in Indore, Central India, the company is committed to the development, production, and marketing of high-quality corticosteroids. It holds certifications from WHO-GMP and ISO 9000:2000, ensuring adherence to international quality standards. By leveraging advanced technology, Symbiotec aims to enhance the production of life-saving APIs, contributing to improved health outcomes for patients while maintaining cost-competitive pricing. The company focuses on meeting the growing demand for steroid-based pharmaceuticals in the global market.

SymbioTec

Private Equity Round in 2018
SymbioTec AG is an engineering company based in Zurich, Switzerland, specializing in cabling systems for L1+ and FTTH infrastructure projects. Established in 2008, it provides enterprise cabling solutions and designs all passive elements for data centers. The company serves a diverse clientele, including notable organizations such as Johnson & Johnson, EWZ, R&M, Sunrise, and Stadtwerke Dusseldorf AG. Since 2009, SymbioTec has operated as a subsidiary of Beacon Enterprise Solutions Group, Inc.

Strides Pharma Science

Private Equity Round in 2018
Strides Pharma Science Limited is a global pharmaceutical company based in Bengaluru, India, specializing in the development, manufacture, and sale of generic and branded pharmaceutical products. Founded in 1990, the company operates through two main business verticals: Regulated Markets and Emerging Markets. Strides offers a wide range of pharma generics, including tablets, capsules, sachets, oral liquids, powders, semi-solids, ointments, and creams. It also develops branded generics for chronic therapies such as women’s health, central nervous system disorders, cardiovascular issues, diabetes, dermatology, and probiotics under various brand names. Additionally, the company produces drugs for infectious diseases like HIV/AIDS, malaria, tuberculosis, and hepatitis. Strides has a global manufacturing footprint with eight facilities across four continents, including five approved by the US FDA. The company's dedicated R&D facility in India supports its strong presence in over 100 countries.

Aizant

Series A in 2017
Aizant is a contract research organization that specializes in providing integrated drug development services. The company partners with both international and domestic pharmaceutical firms to support the development of new molecular entities, generics, and over-the-counter products. Aizant offers a comprehensive range of services, including preformulation, formulation development for conventional and novel drug delivery systems, analytical development, and cGMP scale-up. Additionally, it provides clinical research, project management, bioanalytical development, pharmacokinetics, and biostatistics. By assisting clients throughout the entire research and development process—from molecule discovery to commercialization and life cycle management—Aizant aims to enhance the efficiency and success of pharmaceutical innovations.

Oliva Clinic

Series A in 2017
Oliva Clinic operates a network of medico-aesthetic clinics that specialize in advanced skin and hair treatment services. The clinics are staffed by qualified cosmetic dermatologists, trichologists, and skin and hair therapists, ensuring comprehensive medical assessments and personalized treatment plans tailored to individual needs. By leveraging the latest advancements in medicine, Oliva Clinic aims to enhance the beauty and youthfulness of its patients. The facilities are equipped with modern healthcare equipment, allowing for a thorough analysis of skin and overall medical conditions before recommending appropriate treatments.

Stericon Pharma

Private Equity Round in 2016
Stericon Pharma is a manufacturer specializing in sterile multipurpose contact lens cleaning solutions and sterile eye and nasal formulations. The company offers contract manufacturing services for sterile eye and ear drops tailored to the requirements of pharmaceutical companies and exporters. With over 200 drug licenses, Stericon is equipped to secure additional licenses based on specific customer needs. Additionally, the company provides specialized manufacturing and packaging services for AYUSH (Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homeopathy) products, catering to a diverse range of client demands in the healthcare sector.

Biorad Medisys

Private Equity Round in 2016
Biorad Medisys specializes in the manufacturing and supply of surgical devices and related equipment across various medical fields, including urology, gastroenterology, orthopedic implants, interventional radiology, gynecology, and vascular access. The company's product range includes orthopedic implants such as knee prostheses and various surgical devices and disposables aimed at meeting the needs of patients and healthcare providers. By focusing on these specialized areas, Biorad Medisys aims to enhance the efficiency of medical procedures and improve patient outcomes.

Sandor

Seed Round in 2016
Sandor Medicaids Pvt. Ltd. is a nationwide distribution company specializing in supplies to hospitals and government institutions. It has developed efficient systems and capabilities to supply specialty drugs, device and equipment to hospitals. Since its inception in 1995 in Hyderabad, the company has focused on bringing high-tech biomedical and biotechnology products into India. Sandor has been the first company to bring “Point of Care” concept to the Indian ICU in 1996 by launch of i-stat, a state of the art product for emergency monitoring of patients. The company started as a sales, marketing and distribution company and over time evolved as a nationwide distribution, sales and marketing company by 2008 when Genzyme launched their operations in India. It can today boast of a national level distribution network with 21CFR compliant cold chain facilities covering most of Indian states. Our efficient and compliant 20 branch distribution network supports drug and device manufacturers launch products with ready access to more than 3000 hospitals across India. The company today has more than 180 vendor registrations in Government and private Institutions making it the only partner for foreign or domestic manufacturers to bring their products to hospitals at the most economical costs while maintaining the highest ethical standards. The company has over time developed a strong sales and marketing team which is helping it launch own branded products in select therapeutic area like Critical Care, Nephrology and Transplantation and Pain Management. Our strong presence in Government Institutions has ensured direct sales to all users without help of any sub dealer or liaison agents. The company also provides complete regulatory support to partners and has in-house pharmacovigilance function besides having a strong custom clearing department. A firm foothold in the Indian Hospital procurement system has made Sandor a partner of choice for any new launch of medical drugs, devices and equipment in the Indian Hospital System.

Synergia Life Sciences

Private Equity Round in 2015
Synergia Life Sciences is a manufacturer based in Mumbai, India, specializing in chemicals, pharmaceuticals, and botanical products. The company focuses on producing vitamins, particularly natural vitamin K2-7 (MenaquinGold) and probiotics. These products are developed using exclusively licensed technology and patents, supported by validated analytical methods and comprehensive stability and safety studies. Synergia Life Sciences aims to promote healthier heart and bone health through its innovative offerings.

Comprehensive Prosthetics & Orthotics

Private Equity Round in 2015
Comprehensive Prosthetics & Orthotics is a healthcare company specializing in the manufacture of artificial limbs and orthotic devices for both adults and children. Operating primarily in the Midwest, the company focuses on custom-fabricated products designed to meet the unique needs of each patient. Their offerings include artificial legs and various body parts, all created with precision and rigorous quality standards. The aim is to enhance patient comfort, mobility, and overall functionality, ensuring that individuals receive tailored solutions that improve their quality of life.

Oliva Clinic

Series A in 2014
Oliva Clinic operates a network of medico-aesthetic clinics that specialize in advanced skin and hair treatment services. The clinics are staffed by qualified cosmetic dermatologists, trichologists, and skin and hair therapists, ensuring comprehensive medical assessments and personalized treatment plans tailored to individual needs. By leveraging the latest advancements in medicine, Oliva Clinic aims to enhance the beauty and youthfulness of its patients. The facilities are equipped with modern healthcare equipment, allowing for a thorough analysis of skin and overall medical conditions before recommending appropriate treatments.

Neuland Laboratories

Private Equity Round in 2012
Neuland Laboratories Limited is a manufacturer of active pharmaceutical ingredients (APIs) based in Hyderabad, India. Established in 1984, the company produces APIs for a variety of therapeutic areas, including respiratory, cardiovascular, antifungal, and central nervous system disorders, among others. Neuland serves a global market, deriving a significant portion of its revenue from North America while also catering to customers in Europe and other regions. In addition to API manufacturing, the company offers custom manufacturing solutions and peptide synthesis services, ensuring compliance with international manufacturing standards. Neuland differentiates itself by committing not to compete with its customers in the finished product market.

Anjan Drug

Private Equity Round in 2009
Anjan Drug specializes in the manufacturing of active pharmaceutical ingredients (APIs) for the pharmaceutical industry. The company produces a range of products, including valproic acid, divalproex sodium, magnesium valproate, clorsulon, and pregabalin. These ingredients are manufactured in compliance with Good Manufacturing Practice (GMP) guidelines and are approved by regulatory authorities such as the USFDA, TGA, and EuCOS. Anjan Drug focuses on providing high-quality APIs to drug makers at competitive prices, ensuring that clients have access to the necessary components for their pharmaceutical formulations.

HealthCare Global

Private Equity Round in 2007
HealthCare Global Enterprises Ltd, headquartered in Bangalore, India, is recognized as a leading specialist in cancer care, operating a dedicated network of 20 centers. The organization provides comprehensive and quality cancer treatment, serving approximately 35,000 new patients annually. With a focus on advanced, complicated, and recurrent cancers, HealthCare Global has established a strong reputation both nationally and internationally. The organization's commitment to excellence in oncology was acknowledged with accolades for being a leader in the field in consecutive years, specifically during 2011 and 2012, when it received recognition in the Indian Health Care Awards.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.